RCM Technologies, Inc. Declares Special Cash Dividend of $1.00 per Share
Dec 11, 2017 21:05 pm UTC| Business
PENNSAUKEN, N.J., Dec. 11, 2017 -- RCM Technologies, Inc. (Nasdaq:RCMT), a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers through the...
Dec 11, 2017 21:05 pm UTC| Business
- Ivosidenib and Enasidenib Evaluated in Combination with Standard Induction (7+3) Chemotherapy or Azacitadine in Newly Diagnosed Patients From Two Phase 1 Studies - - Phase 3 Trial of Ivosidenib or Enasidenib Combined...
Aptose Presents New Preclinical Data on CG’806 pan-FLT3/pan-BTK Inhibitor at ASH 59th Annual Meeting
Dec 11, 2017 21:04 pm UTC| Business
SAN DIEGO and TORONTO, Dec. 11, 2017 -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS) today announced the presentation of preclinical data from research led by The University of Texas MD Anderson Cancer Center...
OHSU and Aptose Present CG’806 Preclinical Data at ASH 59th Annual Meeting
Dec 11, 2017 21:04 pm UTC| Business
PORTLAND, Ore. and SAN DIEGO, Dec. 11, 2017 -- The OHSU Knight Cancer Institute and Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS) today announced the presentation of preclinical data demonstrating that CG’806, a...
Dec 11, 2017 21:02 pm UTC| Business
Mechelen, Belgium; 11 December 2017; 22.01 CET; regulated information - Galapagos NV (Euronext NASDAQ: GLPG) received a transparency notification from Fidelity Management Research (FMR) LLC. Pursuant to Belgian...
YRC Worldwide Provides Quarter-To-Date Operating Data for Fourth Quarter 2017
Dec 11, 2017 21:02 pm UTC| Business
OVERLAND PARK, Kan., Dec. 11, 2017 -- YRC Worldwide Inc. (NASDAQ: YRCW) reported certain operating metrics for the first two months of fourth quarter 2017. At YRC Freight, October 2017 tonnage per day increased...
Acer Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
Dec 11, 2017 21:01 pm UTC| Business
NEWTON, Mass., Dec. 11, 2017 -- Acer Therapeutics Inc. (Nasdaq:ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra-rare diseases with...
China's Economic Resurgence: Strong Growth Signals a Bright Future Ahead
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update